Skip to content
Search

Latest Stories

New interim chief executive of Nursing and Midwifery Council resigns 4 days after appointment

New interim chief executive of Nursing and Midwifery Council resigns 4 days after appointment
Staff concerns and past controversies prompt sudden departure from the new role at Nursing and Midwifery Council (NMC)

In the latest development, Dawn Brodrick CB has decided to step down from her recently announced position as the Interim Chief Executive and Registrar of the Nursing and Midwifery Council (NMC), only four days after her appointment.

Brodrick was set to lead the NMC while the council searched for a permanent successor to Andrea Sutcliffe, who is stepping down on July 4 due to ill health.


Previously, Brodrick served as the Chief People Officer at the Crown Prosecution Service, and her career includes roles such as Chief People Officer at King’s College Hospital NHS Foundation Trust and Director of People and Change for the Department of Communities and Local Government.

Upon her appointment, Brodrick expressed enthusiasm for the role, stating, "I understand that I will be joining the NMC at a challenging time.

"I'm passionate about working with people to create positive cultural change and supporting organisations through improvements.

"I hope that my 30 years of experience will help to impact NMC colleagues, nursing and midwifery colleagues, stakeholders, and the public for the better."

However, on Tuesday, the NMC updated its announcement, revealing that Brodrick "has subsequently decided that she will not be taking up the role." The council did not disclose the reason behind this sudden change.

The NMC, which oversees the regulation of nursing and midwifery professions in the UK, is currently navigating a challenging period marked by efforts to improve regulatory and fitness to practice processes.

The organisation is also awaiting the results of an independent review of its culture, including investigations into its handling of whistleblowing concerns and related fitness to practice cases.

According to a news report by The Independent, Brodrick's resignation is linked to staff concerns over her previous role as head of HR at King’s College Hospital.

In 2018, the hospital was ordered to pay £1 million to IT manager Richard Hastings after a tribunal found he was unfairly dismissed and subjected to racial discrimination.

The disciplinary process was criticized for bias and failure to address Hastings' allegations of racial abuse.

Despite initially defending Brodrick's appointment and emphasizing its due diligence, the NMC faced growing internal discontent and external criticism, leading to her resignation.

This development comes ahead of a major review into an alleged "culture of fear" within the NMC, expected next week, following whistleblower reports.

Roger Kline, an NHS race discrimination expert, criticised the NMC's decision to appoint Brodrick, told The Independent:

"The decision by the NMC Council to appoint as chief executive someone whose track record on race discrimination was so open to challenge was a serious mistake."

He emphasised the need for new leadership capable of changing the culture, challenging bullying and racism, and gaining the confidence of staff and registrants to create an NMC fit for purpose for patients.

The NMC will provide an update on the new interim Chief Executive and Registrar later this week.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less